Oscar Health director awarded 858 deferred stock units

Sankaran Sid reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Sankaran Sid reported acquisition or exercise transactions in this Form 4 filing.

Oscar Health, Inc. director Sid Sankaran received a grant of 858 deferred stock units on July 9, 2026, as board compensation elected in lieu of cash retainers. Each unit represents a right to receive one share of Class A common stock, valued at $31.20 per unit based on the closing share price on that date. The units are 100% vested on the grant date and will be settled in cash or shares, at the company’s discretion, within 45 days after termination of service, a change in control, death, or disability. Following this award, Sankaran directly holds 2,061 deferred stock units.

Insider Trade Summary

Grant/Award: 858 shares

Grant/Award 1 txn

Insider Sankaran Sid

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Deferred Stock Unit F1, F3, F2	858	$31.20	$27K

Holdings After Transaction: Deferred Stock Unit — 2,061 contracts (Direct)

Footnotes (3)

1. F1. Each deferred stock unit represents a right to receive one share of the Issuer's Class A common stock.
2. F2. The deferred stock units will be settled for cash or shares of Class A common stock, in the Issuer's discretion, within 45 days of the first to occur of (i) termination of service; (ii) a change in control; (iii) death; or (iv) disability. Deferred stock units issued in lieu of a cash retainer payment are 100% vested on the grant date.
3. F3. The Reporting Person elected, pursuant to the Issuer's Amended and Restated Deferred Compensation Plan for Directors, to receive deferred stock units in lieu of cash retainer payments for service on the Issuer's board of directors. The price of the deferred stock units reported herein represents the closing price of the Issuer's Class A common stock on July 9, 2026, which price was used to calculate the number of deferred stock units issued to the Reporting Person.

Key Figures

Deferred stock units granted: 858 units Unit valuation price: $31.20 per unit Deferred stock units after grant: 2,061 units +1 more

4 metrics

Deferred stock units granted 858 units Grant to director Sid Sankaran on July 9, 2026

Unit valuation price $31.20 per unit Closing price of Class A common stock on July 9, 2026 used to calculate units

Deferred stock units after grant 2,061 units Total deferred stock units directly held by Sid Sankaran following the transaction

Settlement window 45 days Period within which units are settled after specified triggering events

Key Terms

Deferred Stock Unit, change in control, Amended and Restated Deferred Compensation Plan for Directors

3 terms

Deferred Stock Unit financial

"Each deferred stock unit represents a right to receive one share of the Issuer's Class A common stock."

A deferred stock unit (DSU) is a promise from a company to give an employee or director the value of a share at a future date, paid in actual shares or cash when certain conditions are met (such as retirement or a set date). Think of it like a gift card that converts to company stock later; it aligns pay with long‑term performance and can affect future share count, compensation expense and potential cash needs, so investors watch DSUs for their impact on dilution and company finances.

change in control financial

"settled for cash or shares of Class A common stock, in the Issuer's discretion, within 45 days of the first to occur of (i) termination of service; (ii) a change in control; (iii) death; or (iv) disability."

A "change in control" occurs when the ownership or management of a company shifts significantly, such as through a merger, acquisition, or sale of a large part of its assets. This change can impact how the company is run and may influence its future direction. For investors, it matters because it can affect the company's stability, strategy, and value, often signaling potential changes in investment risk or opportunity.

Amended and Restated Deferred Compensation Plan for Directors financial

"The Reporting Person elected, pursuant to the Issuer's Amended and Restated Deferred Compensation Plan for Directors, to receive deferred stock units in lieu of cash retainer payments"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Oscar Health (OSCR) director Sid Sankaran report in this Form 4?

Sid Sankaran reported an award of 858 deferred stock units tied to Oscar Health Class A common stock, received as board compensation in lieu of cash retainer payments on July 9, 2026.

What is the value per deferred stock unit granted to Sid Sankaran at Oscar Health (OSCR)?

Each deferred stock unit was valued at $31.20, equal to the closing price of Oscar Health’s Class A common stock on July 9, 2026, and this price was used to calculate the number of units granted.

How many deferred stock units does Sid Sankaran hold after this Oscar Health (OSCR) transaction?

After the reported grant, Sid Sankaran directly holds 2,061 deferred stock units, each representing a right to receive one share of Oscar Health’s Class A common stock upon settlement events.

How and when will the Oscar Health (OSCR) deferred stock units granted to Sid Sankaran be settled?

The deferred stock units will be settled for cash or Class A shares, at Oscar Health’s discretion, within 45 days after the earlier of termination of service, change in control, death, or disability.

Are the deferred stock units granted to Oscar Health (OSCR) director Sid Sankaran vested?

Yes. The filing states that deferred stock units issued in lieu of a cash retainer payment are 100% vested on the grant date, so the 858 units granted are fully vested immediately.

Why did Oscar Health (OSCR) director Sid Sankaran receive deferred stock units instead of cash?

Sid Sankaran elected, under Oscar Health’s Amended and Restated Deferred Compensation Plan for Directors, to receive deferred stock units in lieu of cash retainer payments for his board service.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/13/2026 - 04:16 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sankaran Sid

(Last) (First) (Middle)

75 VARICK STREET, 5TH FLOOR

(Street)

NEW YORK NEW YORK 10013

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Oscar Health, Inc. [ OSCR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/09/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Deferred Stock Unit	(1)	07/09/2026		A		858		(2)	(2)	Class A Common Stock	858	$31.2(3)	2,061	D

Explanation of Responses:

1. Each deferred stock unit represents a right to receive one share of the Issuer's Class A common stock.

2. The deferred stock units will be settled for cash or shares of Class A common stock, in the Issuer's discretion, within 45 days of the first to occur of (i) termination of service; (ii) a change in control; (iii) death; or (iv) disability. Deferred stock units issued in lieu of a cash retainer payment are 100% vested on the grant date.

3. The Reporting Person elected, pursuant to the Issuer's Amended and Restated Deferred Compensation Plan for Directors, to receive deferred stock units in lieu of cash retainer payments for service on the Issuer's board of directors. The price of the deferred stock units reported herein represents the closing price of the Issuer's Class A common stock on July 9, 2026, which price was used to calculate the number of deferred stock units issued to the Reporting Person.

Remarks:

	/s/ Melissa Curtin, Attorney-in-Fact	07/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)